Fig. 2From: Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction modelGene expression analysis of the fibroblasts using microarray technology. Venn diagram demonstrating differentially expressed genes identified from fibroblasts with pancreatic CCCM (Capan-1 and MIA-PaCa2) stimulation. One hundred and eighty-eight probes with the fold change cut-off of > 2.0 and corrected p-values < 0.05 in either Capan-1 or MIA-PaCa2 were identified (Additional file 1: Table S1). CCCM, cancer-cell-conditioned mediumBack to article page